Do All Babies Congenitally Infected with Zika Develop Microcephaly?
SEP 25, 2016 | CONTAGION EDITORIAL STAFF
Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the likelihood that fetuses congenitally infected with the Zika virus will develop related complications, such as microcephaly.
Interview Transcript (slightly modified for readability)
“[Will] all babies [congenitally infected with Zika virus] develop [complications]? No. You have [a] cohort of pregnant women [from] different places in Brazil that have been followed and we have observed, ourselves and [from] others’ research, that only a small percentage of pregnant women will transmit the virus to [their] fetuses, and the babies will [be] born with microcephaly. Different studies [have] estimated [that] between 1% [and] 13% of these babies will develop severe malformation and microcephaly; not all pregnant women [infected during pregnancies] will [cause] severe [complications] for their babies.
I think that it’s important to remember that almost all infectious disease [have] a large range that range from asymptomatic infections to severe, fatal disease. It’s interesting to observe that, for example, that the percentage of severe disease [resulting from a Zika virus infection], is around 1%, [for] yellow fever [it’s] around 15%. So now, trying to estimate the severity of [Zika virus infection], I’m sure that not all fetuses that [are] infected will present [with] severe disease. It’s important to [keep] this in mind, because the number of infected babies that will not present [with complications] perhaps can be higher than the number of babies that will present [with] severe disease, like microcephaly or other malformations. This is natural because all infectious diseases have a range of the disease’s severity. In [the] case of Zika, it is estimated that around 80% of all infections will be asymptomatic, [meaning infection] will not cause symptoms.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512